Literature DB >> 16450332

Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.

Willem J M Mulder1, Gustav J Strijkers, Geralda A F van Tilborg, Arjan W Griffioen, Klaas Nicolay.   

Abstract

In the field of MR imaging and especially in the emerging field of cellular and molecular MR imaging, flexible strategies to synthesize contrast agents that can be manipulated in terms of size and composition and that can be easily conjugated with targeting ligands are required. Furthermore, the relaxivity of the contrast agents, especially for molecular imaging applications, should be very high to deal with the low sensitivity of MRI. Lipid-based nanoparticles, such as liposomes or micelles, have been used extensively in recent decades as drug carrier vehicles. A relatively new and promising application of lipidic nanoparticles is their use as multimodal MR contrast agents. Lipids are amphiphilic molecules with both a hydrophobic and a hydrophilic part, which spontaneously assemble into aggregates in an aqueous environment. In these aggregates, the amphiphiles are arranged such that the hydrophobic parts cluster together and the hydrophilic parts face the water. In the low concentration regime, a wide variety of structures can be formed, ranging from spherical micelles to disks or liposomes. Furthermore, a monolayer of lipids can serve as a shell to enclose a hydrophobic core. Hydrophobic iron oxide particles, quantum dots or perfluorocarbon emulsions can be solubilized using this approach. MR-detectable and fluorescent amphiphilic molecules can easily be incorporated in lipidic nanoparticles. Furthermore, targeting ligands can be conjugated to lipidic particles by incorporating lipids with a functional moiety to allow a specific interaction with molecular markers and to achieve accumulation of the particles at disease sites. In this review, an overview of different lipidic nanoparticles for use in MRI is given, with the main emphasis on Gd-based contrast agents. The mechanisms of particle formation, conjugation strategies and applications in the field of contrast-enhanced, cellular and molecular MRI are discussed. 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16450332     DOI: 10.1002/nbm.1011

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  124 in total

Review 1.  Molecular body imaging: MR imaging, CT, and US. part I. principles.

Authors:  Moritz F Kircher; Jürgen K Willmann
Journal:  Radiology       Date:  2012-06       Impact factor: 11.105

2.  Albumin-based nanoparticles as magnetic resonance contrast agents: II. Physicochemical characterisation of purified and standardised nanoparticles.

Authors:  A A Abdelmoez; G C Thurner; E A Wallnöfer; N Klammsteiner; C Kremser; H Talasz; M Mrakovcic; E Fröhlich; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-07-14       Impact factor: 4.304

3.  Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.

Authors:  Jaeyun Kim; Lan Cao; Dmitry Shvartsman; Eduardo A Silva; David J Mooney
Journal:  Nano Lett       Date:  2010-12-30       Impact factor: 11.189

4.  Nanodiscs as a Modular Platform for Multimodal MR-Optical Imaging.

Authors:  Christiane E Carney; Ivan L Lenov; Catherine J Baker; Keith W MacRenaris; Amanda L Eckermann; Stephen G Sligar; Thomas J Meade
Journal:  Bioconjug Chem       Date:  2015-04-09       Impact factor: 4.774

5.  Interaction of Huntingtin Exon-1 Peptides with Lipid-Based Micellar Nanoparticles Probed by Solution NMR and Q-Band Pulsed EPR.

Authors:  Alberto Ceccon; Thomas Schmidt; Vitali Tugarinov; Samuel A Kotler; Charles D Schwieters; G Marius Clore
Journal:  J Am Chem Soc       Date:  2018-05-14       Impact factor: 15.419

6.  Color Tunable Gd-Zn-Cu-In-S/ZnS Quantum Dots for Dual Modality Magnetic Resonance and Fluorescence Imaging.

Authors:  Weisheng Guo; Weitao Yang; Yu Wang; Xiaolian Sun; Zhongyun Liu; Bingbo Zhang; Jin Chang; Xiaoyuan Chen
Journal:  Nano Res       Date:  2014-11-01       Impact factor: 8.897

7.  Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle.

Authors:  Paul S Sheeran; Jason E Streeter; Lee B Mullin; Terry O Matsunaga; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2013-02-27       Impact factor: 2.998

8.  The effect of cryoprotection on the use of PLGA encapsulated iron oxide nanoparticles for magnetic cell labeling.

Authors:  Kevin S Tang; Sarah M Hashmi; Erik M Shapiro
Journal:  Nanotechnology       Date:  2013-03-04       Impact factor: 3.874

9.  Conquering the dark side: colloidal iron oxide nanoparticles.

Authors:  Angana Senpan; Shelton D Caruthers; Ilsu Rhee; Nicholas A Mauro; Dipanjan Pan; Grace Hu; Michael J Scott; Ralph W Fuhrhop; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Journal:  ACS Nano       Date:  2009-12-22       Impact factor: 15.881

Review 10.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.